Formulations for anaesthetic use
US7326735B2 · kind B2 · utility
2Cited by
2References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2004 |
| Grant date | Feb 5, 2008 |
| Priority date | — |
| Expiry date | Dec 31, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A formulation for anaesthetic use is described. The formulation contains propofol, and may be used to induce and/or maintain anaesthesia or sedation in a vertebrae. The formulation additionally contains a solvent or a combination of solvents and is suitable for mixing with commonly used infusion fluids prior to injection in to a patient. The formulation may be terminally sterilised using moist heat in order to assure sterility, and contains no lipid, thereby avoiding complications associated with administration over prolonged periods of time, or to patients with disorders of fat metabolism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.